Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis

Status Completed

Clinical Trial Summary

The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of intracameral moxifloxacin for prevention of postcataract endophthalmitis.

Clinical Trial Description

Although cataract surgery is generally considered a safe procedure resulting in a favourable visual outcome, surgical complications do occur. The most feared complication is postoperative endophthalmitis which is an infectious condition caused by micro-organisms introduced to the interior of the eye during or after the surgical procedure.

As endophthalmitis is an infection, it should be preventable by antibiotic treatment.

Prophylactic antibiotic treatment can be given as topical treatment preoperatively, or during surgery directly into the anterior chamber, or as a subconjunctival, or it can be given as topical treatment postoperatively.

The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of intracameral moxifloxacin for prevention of postcataract endophthalmitis. ;

Study Design

Related Conditions & MeSH terms

Endophthalmitis

Clinical Trial Details

NCT number	NCT02595359
Study type	Interventional
Source	Universidade Federal de Pernambuco
Contact
Status	Completed
Phase	Phase 2
Start date	January 2013
Completion date	June 20, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04214821` - The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%	Phase 1/Phase 2
Completed	`NCT00461656` - Povidone-iodine Antisepsis for Strabismus Surgery	Phase 4
Completed	`NCT00136344` - Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery	N/A
Completed	`NCT04568213` - Hypochlorous Acid Disinfection Prior to Cataract Surgery	Phase 3
Terminated	`NCT01496794` - Endophthalmitis Cultures	N/A
Completed	`NCT00406913` - Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery	N/A
Recruiting	`NCT05079854` - Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis	Phase 4
Recruiting	`NCT05432336` - Complex Ocular Infection, Optimization of Microbiological Diagnosis
Recruiting	`NCT02810587` - Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics	N/A
Completed	`NCT00398658` - Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis	Phase 4
Recruiting	`NCT04035369` - Endophthalmitis Post Intravitreal Injections	N/A
Not yet recruiting	`NCT03420820` - Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection	N/A
Recruiting	`NCT06268561` - Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
Withdrawn	`NCT00335231` - Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery	N/A
Not yet recruiting	`NCT03244072` - Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery	Phase 2/Phase 3
Completed	`NCT01323868` - Endogenous Endophthalmitis in the Inpatient Setting	N/A
Completed	`NCT03363295` - Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis	Phase 4
Suspended	`NCT02590523` - Intracameral Antibiotic Safety Study	Phase 3
Terminated	`NCT02770729` - Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.	Phase 3
Not yet recruiting	`NCT02324166` - Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain	Phase 4